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Abstract
Background: Self-management by people with type 2 diabetes is central to good health outcomes and the
prevention of associated complications. Structured education to teach self-management is recommended by the
National Institute for Heath and Clinical Excellence; however, only a small proportion of patients report being offered
this education and even fewer attend. This study aims to evaluate the implementation of a new internet-based
self-management intervention: HeLP-Diabetes (Healthy Living for People with type 2 Diabetes) within the National
Health Service. Specific objectives are to a) determine the uptake and use of HeLP-Diabetes by services and patients;
b) identify the factors which inhibit or facilitate use; c) identify the resources needed for effective implementation;
d) explore possible effects of HeLP-Diabetes use on self-reported patient outcome measures.
Methods/Design: This study will use an iterative design to implement HeLP-Diabetes into existing health services
within the National Health Service. A two stage implementation process will be taken, whereby batches of General
Practice surgeries and diabetes clinics will be offered HeLP-Diabetes and will subsequently be asked to participate in
evaluating the implementation. We will collect data to describe the number of services and patients who sign up to
HeLP-Diabetes, the types of services and patients who sign up and the implementation costs. Semi-structured interviews
will be conducted with patients and health professionals and cohorts of patient participants will be asked to complete
self-report measures at baseline, 3 months, and 12 months.
Discussion: This study will evaluate the implementation of a new online self-management intervention and
describe what happens when it is made available to existing National Health Services and patients with type 2
diabetes. We will collect data to describe the uptake and use of the intervention and the resources needed for
widespread implementation. We will report on patient benefits from using HeLP-Diabetes and the resources
needed to achieve these in routine practice. Interviews with key stake holders will identify, define and explain
factors that promote or inhibit the normalization of new patterns of patient and professional activity arising from
HeLP-Diabetes.
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Background
Diabetes is one of the most common long-term con-
ditions in the UK affecting around 4.5 per cent of the
population. It is a leading factor in the development of
chronic illnesses and complications including coronary
heart disease, renal failure and blindness, as well as
reducing life expectancy [1]. Diabetes and related
complications put considerable strain on health budgets
with the estimated cost to the National Health Service
(NHS) of £14 billion a year [2].
Self-management by the patient is central to good dia-
betes care [3-5], and structured education in which the
knowledge and skills necessary for self-management are
taught, has been found to provide a fourfold decrease in
the risk of complications developing [6]. Structured
education at diagnosis with annual reinforcement is
recommended by the UK’s National Institute for Health
and Clinical Excellence (NICE) for all people with type 2
diabetes (T2DM). However, only 8.7 per cent of people
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with T2DM who were newly diagnosed in 2008–2009
reported being offered structured education during
2009–2011 while only 3.6 per cent reported actually
attending structured education [7].
Structured education, currently delivered as a group
based activity, may be particularly unsuitable for people
with caring responsibilities, some ethnic minority popu-
lations, those with physical disabilities and those who
find group interactions challenging. With NHS resources
unlikely to increase for such education and the poor
referral and uptake of existing programmes there is an
urgent need for new cost effective ways of delivering
self-management education which are acceptable to pa-
tients and clinicians. The use of new information and
communication technologies to improve health and
health care is now a central part of NHS policy, and
NHS Choices is already delivering a number of websites
although many of these have yet to be evaluated.
The internet offers huge potential for delivering public
health interventions [8]. Internet- based interventions
have a number of potential benefits including conve-
nience, accessibility, anonymity and may be cost-effective
in delivering education to large numbers of people.
Although the current evidence on the use of new tech-
nology in diabetes is still evolving, positive effects of such
interventions have been demonstrated in several studies.
A Cochrane systematic review of interactive healthcare
applications looked at 24 randomised control trials (RCTs)
in a range of chronic diseases including diabetes. It found
mostly positive effects, with users tending to become
more knowledgeable, feel better supported, with possible
improved behavioural and clinical outcomes compared
with non-users [9]. Another systematic review produced a
narrative report of interactive computer-assisted tech-
nology in diabetes care [10]. It identified 14 studies that
looked at HbA1c levels (a measure of glucose metabolism
which reflects average blood glucose levels over six to
eight weeks) and found that 6 of 14 studies demonstrated
significant improvements in HbA1c. The interventions
also appeared to improve healthcare utilisation with more
foot examinations and HbA1c monitoring. Evidence from
a recent systematic review of 16 RCTs suggests internet-
based self-management programmes for people with
T2DM can improve HbA1c [11]. This review suggested
that these positive effects on HbA1c may decrease over
time, which is similar to the effects of more traditional
group-based self-management education on HbA1c which
also show a similar decline in benefits over time [4,12,13].
The American Diabetes Association standards for self-
management education recognise the need for both initial
training and subsequent on-going support to try and
maintain the benefits of educational interventions [14].
Internet-based interventions are ideally suited to pro-
viding ongoing self-management support that could allow
sustained improvements and long-term improvements in
outcomes.
We have developed an internet based self-management
intervention for people with T2DM: ‘HeLP-Diabetes:
Healthy Living for People with Type 2 Diabetes’. The
design of this complex intervention has been informed by
theory and the needs and preferences of patients and
health professionals. It has been developed using a process
of participatory design with users (people with T2DM and
health professionals) heavily involved in the conception
and creation. HeLP-Diabetes takes a holistic view of self-
management and addresses a wide range of patient needs
including education, lifestyle changes, medicine manage-
ment, emotional management, social support with forums
and personal stories and also addresses how patients inter-
act and work with health professionals. A facility to inter-
face with patients electronic medical records has been
designed to provide patients access to self-management
metrics recorded by General Practice (GP) surgeries. The
information provided on HeLP-Diabetes is based on NICE
guidelines and has been developed to complement exis-
ting structured group education.
This study will explore the implementation of HeLP-
Diabetes within the NHS, addressing the facilitators and
barriers associated with initial and continued engagement
by staff and patients and the resources required to make
HeLP-Diabetes a viable part of routine diabetes care. This
implementation study is being conducted in parallel to a
randomised control trial of the HeLP-Diabetes interven-
tion. The Medical Research Council (MRC) framework
for complex interventions [15] stresses the importance of
considering the implementation of complex interventions
throughout the development and evaluation phases in a
cyclical and iterative way. The data provided by this imple-
mentation study will provide additional outcome data to
that provided by the trial including data that will be
essential for commissioners of care such as data on what
happens in practice, and what actions and resources are
needed for successful implementation and realisation of
potential benefits.
Aim
To explore the implementation of HeLP-Diabetes within
NHS GP surgeries and hospital and community based
diabetes clinics.
Objectives
a. To describe the uptake and use of HeLP-Diabetes by
NHS services and patients.
b. To identify factors which inhibit or facilitate
implementation.
c. To identify the resources needed for effective
implementation.
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d. To explore any effects of HeLP-Diabetes use on
self-reported patient outcomes.
Theoretical framework
Literature on the transfer of research into clinical prac-
tice consistently reports the process as unpredictable,
slow and haphazard [16]. The explicit use of theory in
implementation research may support a better under-
standing of the generalisability and replicability of im-
plementation interventions [17]. The MRC framework
emphasises that the development, evaluation and imple-
mentation of health care interventions requires a strong
theoretical foundation [15].
We have selected Normalisation Process Theory
(NPT) [18,19] to provide a theoretical underpinning to
this study. NPT can be used as a theoretical framework
to identify factors that promote and inhibit the routine
incorporation of complex interventions into everyday
practice. It explains how these interventions work in
practice (or fail to), looking not only at early implemen-
tation, but beyond this to the point where an interven-
tion becomes so embedded into routine practice that it
‘disappears’ from view (i.e., it is normalised) [20]. We
will use NPT as an explanatory framework to explore
the implementation process and to guide interviews with
NHS staff. The use of NPT will provide a transferable
understanding of the success or failure of the HeLP-
Diabetes integration into routine NHS practice, provi-
ding learning opportunities for future studies.
Methods/Design
Design
This will be a longitudinal cohort study using qualitative
and quantitative methods.
Setting
The study will be conducted in GP surgeries, community
diabetes clinics and hospital based diabetes clinics within
two inner city London boroughs: There are approxi-
mately 80 GP surgeries, two services providing a range
of community diabetes clinics and three hospitals run-
ning diabetes clinics within these two boroughs. Our
aim is to make HeLP-Diabetes available to up to 30 GP
surgeries and all diabetes clinics. Within these boroughs
there are 16,223 people on GP registers with a recorded
diagnosis of diabetes [21]. Since T2DM accounts for 90%
of all diabetes cases, there are up to 14,601 potential
users of HeLP-Diabetes within these two boroughs.
Procedure
The use of HeLP-Diabetes will be offered to GP sur-
geries and diabetes clinics free of charge for the duration
of the study (30 months). HeLP-Diabetes will be made
available to batches of GP surgeries and clinics (approx.
2 or 3 at a time). This will allow learning and experience
gained from the implementation at each batch of sites to
be transferred to subsequent ones. Once organisations
have agreed to use HeLP-Diabetes they will be asked to
opt-in to the research evaluation study. Organisations
who opt-out of the research evaluation will still be free
to use HeLP-Diabetes without participation in the
research.
Staff working in services that agree to use HeLP-
Diabetes will be asked to recommend its use to all suitable
patients with T2DM and refer them to a training appoint-
ment with a researcher or a member of the clinical team.
Suitable times to recommend the use of HeLP-Diabetes
may include at annual diabetes reviews and when a patient
is newly diagnosed. Staff will also be encouraged to main-
tain engagement with HeLP-Diabetes by encouraging
patients to use it at appropriate times during routine
consultations.
During training appointments patients will be regis-
tered on the HeLP-Diabetes site and shown how to use
it. Each appointment will be tailored to the specific
needs of the patient and will focus on an aspect of dia-
betes self-management important to the patient. At the
end of the training appointment patients will be invited
to take part in the research study evaluating the imple-
mentation of HeLP-Diabetes. Patients who agree to take
part in the evaluation study will be asked to sign a con-
sent form after reading the participant information sheet
and having the opportunity to ask any questions. Pa-
tients who opt-out of the research evaluation will still be
free to use HeLP-Diabetes without participation in the
research.
Ethical consideration
Ethical approval for this study was gained from the
NRES Committee East Midlands-Leicester ref: 13/EM/
0033.
Recruitment
Recruitment will happen at both organisational and pa-
tient level.
Both organisations and patients will be recruited firstly
to use HeLP-Diabetes and secondly to take part in the
research evaluation of the implementation.
Organisational
Strategies being explored to recruit organisations to
use HeLP-Diabetes include engagement of the Clinical
Commissioning Groups (CCG), direct contacts with
hospital and community based clinics and the assistance
of the North Central London Research Consortium
(NoCLOR) to recruit GP surgeries.
Staff in participating services who opt in to the re-
search evaluation will be invited to take part in research
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activities on an opportunistic basis throughout the study
period.
Patient
Once a GP surgery or diabetes clinic has agreed to use
HeLP-Diabetes, recruitment to use HeLP-Diabetes at the
patient level will begin. Health professionals in par-
ticipating GP surgeries and clinics will be asked to re-
commend the use of HeLP-Diabetes to all patients with
T2DM who meet the inclusion criteria and to refer them
to a training appointment. At the end of training ap-
pointments, eligible patients will be asked to participate
in the research study evaluating the implementation of
HeLP-Diabetes.
Sample
Staff
A range of staff from GP surgeries and diabetes clinics
including consultants, salaried doctors, junior hospital
doctors, general practice partners, general practice man-
agers, practice nurses, community nurses, hospital dia-
betes nurses and reception staff will be recruited to
participate in the research evaluation study. The aim is
to represent a range of perspectives of the staff who con-
tribute to the care of patients with T2DM on the imple-
mentation of HeLP-Diabetes.
Patient
To use HeLP-Diabetes and participate in the evaluation
study, patients must be 18 or above, registered at par-
ticipating GP surgeries, community diabetes clinics or
hospital based diabetes clinics and have a diagnosis of
T2DM. Patients will be excluded from the research
evaluation if they are unable to provide informed con-
sent, e.g. due to psychosis, dementia or severe learning
disabilities, are terminally ill (life expectancy less than 12
months), unable to use a computer due to physical or
mental impairment or possess English language skills in-
sufficient to use the intervention.
Implementation plan
An implementation plan has been devised by the re-
search team which will be offered to all services. This
plan includes the following steps; an initial meeting at
the GPsurgery or clinic to explain the new HeLP-
Diabetes service, a demonstration of HeLP-Diabetes,
training for staff who will be using HeLP-Diabetes top-
up training and support as necessary, training patients
to use HeLP-Diabetes, follow up contact with patients,
continued monitoring and feedback to staff, and the
provision of training materials to staff and patients. Each
GP surgery and diabetes clinic will be invited to work
with researchers to tailor the implementation plan to the
individual setting.
The researcher will spend time with staff to implement
HeLP-Diabetes and to provide support and facilitate pa-
tient training appointments. Formal feedback from inter-
views with staff and patients and informal feedback such
as lessons learned from training staff and patients will be
used by the researcher to develop and refine the imple-
mentation procedures. The iterative design will allow the
implementation plan to be tested out on a small scale,
the researcher to learn from the experience and modifi-
cations to be made to plan before testing it on a another
small number of services. This method will allow for dif-
ficulties and challenges to be explored and addressed,
which may otherwise be missed by widespread imple-
mentation. Through the process of modifying the imple-
mentation plan based on feedback from patients and
staff and by allowing the implementation plan to be tai-
lored to individual sites, we hope to increase buy-in and
ownership of HeLP-Diabetes by staff and reduce barriers
to successful implementation.
Outcomes
The study objectives will be addressed in the following
ways.
a. To describe the uptake and use of HeLP-Diabetes by
NHS services and patients.
The number of GP surgeries and diabetes clinics
HeLP-Diabetes is offered to, and the numbers who
take it up will be recorded. To describe the types
of services that take up HeLP-Diabetes we will
collect data including: the number of patients
registered at the surgery or who attend the clinic
(overall numbers and those with T2DM), socio
demographics of the patient population and the
number of staff. For GP surgeries we will also
collect: Quality and Outcomes Framework (QOF)
achievement and whether it is a training or
non-training practice.
The number of patients who register on HeLP-
Diabetes will be recorded and patient registration
data will be used to describe the characteristics of
patients who sign up. This data will include; year
of birth, gender, ethnicity, the surgery or clinics
they attend, duration of diabetes, existence of
complications, how diabetes is currently
managed; what help the patient would like with
self-management, smoking status, internet
access (home/public) and use of computer
(basic/intermediate/advanced).
Data on HeLP-Diabetes use will be recorded
automatically by the website software and Google
Analytics and will include number of logins, length
of time patients use HeLP-Diabetes per visit, pages
that are visited and those that are not, and the
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tools, assessments, educational modules that are
used and how often.
b. To identify factors which inhibit or facilitate
implementation.
Semi-structured interviews will be conducted with
key informants, both patients and health
professionals and will be focussed on exploring the
barriers and facilitators to implementation. The
researcher will also keep detailed notes on the
implementation process and document any
challenges and successes.
c. To identify the resources needed for effective
implementation.
A proforma will be used to collect quantitative data
on the resources spent on implementing HeLP-
Diabetes, which are predicted to be largely made up
of staff and researcher time. Semi-structured inter-
views will be conducted with key informants, both
patients and health professionals, to investigate the
resources needed for effective implementation.
d. To explore the effects of HeLP-Diabetes on
self-reported patient outcomes.
Patient participants will be asked to complete two
self-report measures. The first will be the Problem
Areas in Diabetes (PAID) scale [22] which is a
health related quality of life and emotional distress
measure. It is comprised of 20 items focusing on
areas that cause difficulty for people living with
diabetes including; social situations, food, friends
and family, diabetes treatment, emotions,
relationships with healthcare professionals and
social support. The second measure will be the
Diabetes Management Self-Efficacy Scale
(DMSES-UK) [23] which measures the individual’s
efficacy expectations for engaging in 20 diabetes
self-management activities, for example, taking
daily exercise and keeping to a healthy eating plan
when away from home. A sample size of 100 pa-
tients will detect a 3.5 point difference in the mean
PAID score from baseline and a 9 point difference
in the mean DMSES score from baseline. These
calculations are based on 90% power (α = 0.05).
Additional self-report measures may be introduced
to new cohorts of patients in order to test
developing hypotheses generated by interviews with
patients and staff. For example, if a theme emerges
from the interviews suggesting that using HeLP-
Diabetes may increase patients’ levels of physical
activity, we may administer a physical activity
self-report measure to a new cohort of patients at
baseline, 3 months and 12 months to quantitatively
explore this. Power and sample size will be
calculated for each new measure prior to it being
administered.
Data collection
After consenting to take part in the evaluation research
study, patient participants will be allocated a unique study
ID number and complete baseline measures. Participants
will be asked to provide their email address, postal address
and contact number for data collection purposes. They
will be sent a link in an email to a web-based case report
form which will host the data collection measures. The
data entered into this form will be anonymous and only
linked to the patient by the unique ID number. Parti-
cipants will be asked to complete socio-demographic in-
formation at baseline and self-report measures at baseline,
3 months and 12 months. Socio-demographic information
will be collected to describe the sample, and to compare
intervention use and self-report measure data.
Both patient and health professional participants will
be asked to take part in semi-structured interviews.
Each participant may be interviewed several times
throughout the course of the study. We will sample
until saturation is reached. In order to capture a
breadth of experiences interviews will be conducted
with patients from a range of ethnic backgrounds, ages,
socio-demographic statuses, length of time with dia-
betes, treatment types, and associated complications,
as well as a range of experience with computers and
the internet. Similarly, to capture a range of staff expe-
riences, we will seek to interview consultants, salaried
doctors, junior hospital doctors, general practice part-
ners, general practice managers, practice nurses, com-
munity nurses, hospital diabetes nurses and reception
staff from GP surgeries and diabetes clinics. It is likely
that there will be different levels of engagement with
HeLP-Diabetes and with the evaluation research study
between different members of staff and between differ-
ent services and sites. Therefore, not all interviews will
be face to face; initial interviews and follow-up en-
counters with some participants may be short, highly
focused telephone interviews. These will minimise the
demand on participants, and is likely to be much more
cost effective. However, more in-depth, semi struc-
tured interviews will be conducted with participants
wherever possible. Participants may be sampled pur-
posefully at times to ensure that we have captured a
range of experiences and opinions.
Data on intervention use will be recorded automati-
cally by the intervention software and Google Analytics
and will be downloaded into a spread sheet. Data on
the type of GP surgeries and diabetes clinics that take
up HeLP-Diabetes will be collected from Population
Manager Data, Public Health Observatories [21] data
and a data collection form to be completed by the
Practice Manager or Clinic Lead at each site. The time
spent by individuals involved in the implementation of
HeLP-Diabetes will be recorded on a proforma.
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Anaylsis
The proportion of GP surgeries and clinics offered HeLP-
Diabetes who adopt it, the number of patients who
register on HeLP-Diabetes, the socio-demographic charac-
teristics of the patients who take part in the evaluation
study and the characteristics of the clinics and GP sur-
geries that adopt HeLP-Diabetes will be described using
descriptive statistics. SPSS statistical software [24] will be
used for coding and analysing these data. Descriptive
statistics will also be used to explain how patients make
use of HeLP-Diabetes including counts of pages accessed,
number of logins, the times of use, the duration of use
and the patterns of use by different users. This data will be
recorded automatically by the website software. The time
and other resources expended on implementing HeLP-
Diabetes will be recorded on a proforma and these will
be collated on a spread sheet and data described
descriptively.
The cost of health professional input from the GP sur-
geries and clinics will be based on national average rates
using Personal Social Services Research Unit estimates.
Estimates of the additional time required from the
general practice and clinic staff where HeLP-Diabetes is
implemented will be calculated from responses in the
qualitative interviews. Resources required in training in-
dividual patients to use HeLP-Diabetes will be estimated.
Participant scores on the PAID and DSMSE-UK scales
will be compared statistically at the different time points
using a repeated measures analysis of variance test using
time as the independent variable. If a statistically sig-
nificant effect is found post-hoc tests will be used to ex-
plore this further. Follow up PAID and DSMSE-UK
scores will be adjusted for initial scores and other base-
line covariates including age, gender, and duration of
diabetes. Group effects including gender and age will be
assessed using mixed-between within subjects analysis of
variance.
With respondents’ consent, all semi-structured inter-
views will be audio-recorded, transcribed (and edited to
ensure anonymity of respondent) and data will be sub-
jected to formal analysis. Patient and staff interviews will
be analysed inductively to identify themes and cate-
gories, a process of constant comparison will be used to
establish analytical categories. Atlas. ti [25] data collation
and management software will be used to aid data man-
agement and analysis.
Discussion
This study will explore what happens when a new
internet-based self-management intervention for patients
with T2DM is introduced into existing NHS services.
Quantitative data will describe the use of HeLP-Diabetes
by NHS organisations and patients and allow us to de-
termine the socio-demographic characteristics of users
and the type of service that take up HeLP-Diabetes. We
will determine the cost of implementation and the re-
sources needed for successful implementation. Qualita-
tive data will allow us to understand the implementation
process and explore barriers and facilitators to imple-
menting HeLP-Diabetes into existing services. We will
explore the possible impact of HeLP-Diabetes use on
patient-reported health-related quality of life, emotional
wellbeing and self-efficacy to self-manage T2DM. This
study will produce findings useful for those embarking
on the implementation of an internet based resource
within the NHS.
Translating research into routine clinical practice is
often a difficult task. Implementation research is often fo-
cused on the early stages of the implementation process
[26] however, there is also a need to examine later stages
of implementation, including the integration of innova-
tions into the norms and practices of organisations.
Exploring the implementation of HeLP-Diabetes with a
longitudinal study over 30 months will provide an op-
portunity to examine issues and challenges that emerge
during the many stages of implementation including the
less researched later stages.
There are several strengths of the design of this study.
Data on the implementation of HeLP-Diabetes will be
collected from staff across diabetes services and from a
range of staff within these services. This will include
both management and front-line staff as these groups
may have very different viewpoints and perceptions of
organisational change [27].
The iterative design of the study will allow for the im-
plementation plan to change and develop in line with
experiential learning and feedback from those involved
in the implementation process. This is important in
creating a final implementation procedure that is fit for
purpose and effective. The mixed method design will aid
the process of exploring the impact of HeLP-Diabetes on
patient outcomes. By conducting interviews with pa-
tients throughout the study, emerging themes pertaining
to the possible benefits of HeLP-Diabetes can be
explored in greater detail with further interviews. We
can also test emerging hypotheses about the mecha-
nisms of action borne out of the interviews by adminis-
tering further self-report measures to new cohorts of
patients at baseline, 3 month and 12 month follow up.
The study faces some potential methodological and
practical challenges. The study is limited to two inner
London boroughs; the patient population and the ser-
vices within which we are seeking to implement HeLP-
Diabetes which may limit the generalizability of findings.
In terms of studying the patient experience of HeLP-
Diabetes, only the views of those patients who agree to
take part in the research evaluation will be included.
The views of those who don’t use HeLP-Diabetes and
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those using it but not taking part in the research study
will not be represented.
The need for patients to attend a training appointment
to use HeLP-Diabetes may be a potential bottle-neck to
uptake. However, we believe that this tailored appoint-
ment will ensure that patients can use HeLP-Diabetes
optimally. A research question to be addressed within
this study is what is the most effective and viable way to
ensure HeLP-Diabetes is a useful, effective and sustain-
able resource for patients and the evaluation of this
training appointment will be central to that.
It is likely that internet-based health interventions will
become increasingly widespread, not just for diabetes
but for other long term physical conditions and mental
health problems. There is a need to understand the im-
plementation process of these interventions including
the uptake by health organisations and patients, the fa-
cilitators and barriers to use and the resources needed
for successful implementation and normalization. This
study will offer a contribution to this.
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